Prequalified vaccines
Displaying 1 - 50 of 262
Download list as CSV file
| Date of Prequalification | WHO Product ID | Vaccine type | Commercial Name Sort descending | Pharmaceutical Form | Presentation | No. of doses | Manufacturer | Responsible NRA |
|---|---|---|---|---|---|---|---|---|
| FVP-P-app8 | Diphtheria, tetanus and (whole cell) pertussis vaccine (adsorbed) | Sanofi Healthcare India Private Limited | Central Drugs Standard Control Organization (CDSCO) | |||||
| FVP-P-109 | Haemophilus influenzae type b conjugate vaccine | Act-HIB | Lyophilised active component to be reconstituted with excipient diluent before use | Vial | 1 | Sanofi Pasteur SA | Agence nationale de sécurité du médicament et des produits de santé (ANSM) | |
| FVP-P-315 | Diphtheria, tetanus and (acellular) pertussis vaccine (adsorbed) | Adacel | Liquid: Ready to use | Vial | 1 | Sanofi Pasteur Limited | Health Canada | |
| FVP-P-7 | Diphtheria and tetanus vaccine (adsorbed) | Adsorbed DT Vaccine | Liquid: Ready to use | Vial | 10 | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia (NADFCI) | |
| FVP-P-367 | Influenza vaccine trivalent (split virion, inactivated) | Afluria® | Liquid: Ready to use | Vial | 10 | Seqirus Australia Pty Ltd | US Food and Drug Administration- Office of Vaccine Research and Review (US FDA) | |
| FVP-P-350 | Influenza vaccine quadrivalent (split virion, inactivated) | Afluria® Quadrivalent | Liquid: Ready to use | Vial | 10 | Seqirus Australia Pty Ltd | US Food and Drug Administration- Office of Vaccine Research and Review (US FDA) | |
| FVP-P-316 | Influenza vaccine trivalent (surface antigens, inactivated) | AGRIFLU | Liquid: Ready to use | Vial | 10 | Seqirus UK Limited | Health Canada | |
| FVP-P-406 | Varicella | BARYCELA inj. | Lyophilised active component to be reconstituted with excipient diluent before use | Vial | 1 | GC Biopharma Corporation | Ministry of Food and Drug Safety (MFDS) | |
| FVP-P-338 | BCG | BCG Freeze Dried Glutamate vaccine | Lyophilised active component to be reconstituted with excipient diluent before use | Ampoule | 10 | Japan BCG Laboratory (JBL) | Pharmaceutical and Medical Devices Agency (PMDA) | |
| FVP-P-67 | BCG | BCG Freeze Dried Glutamate vaccine | Lyophilised active component to be reconstituted with excipient diluent before use | Ampoule | 20 | Japan BCG Laboratory (JBL) | Pharmaceutical and Medical Devices Agency (PMDA) | |
| FVP-P-117 | BCG | BCG Vaccine | Lyophilised active component to be reconstituted with excipient diluent before use | Vial | 20 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-74 | BCG | BCG Vaccine | Lyophilised active component to be reconstituted with excipient diluent before use | Ampoule | 20 | Bul Bio-National Center of Infectious and Parasitic Diseases Ltd. | Bulgarian Drug Agency (BDA) | |
| FVP-P-73 | BCG | BCG Vaccine | Lyophilised active component to be reconstituted with excipient diluent before use | Ampoule | 10 | Bul Bio-National Center of Infectious and Parasitic Diseases Ltd. | Bulgarian Drug Agency (BDA) | |
| FVP-P-164 | BCG | BCG Vaccine AJV | Lyophilised active component to be reconstituted with excipient diluent before use | Two vial set (active + excipient) | 10 | AJ Vaccines A/S | Danish Medicines Agency | |
| FVP-P-291 | Poliomyelitis vaccines (trivalent live, oral, innactivated, type 1,2, 3) | BIOPOLIO | Liquid: Ready to use | Vial | 10 | Bharat Biotech International Limited | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-290 | Poliomyelitis vaccines (trivalent live, oral, innactivated, type 1,2, 3) | BIOPOLIO | Liquid: Ready to use | Vial | 20 | Bharat Biotech International Limited | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-244 | Poliomyelitis vaccines (bivalent live, oral, innactivated, type 1, 3) | BIOPOLIO B1/3 | Liquid: Ready to use | Vial | 20 | Bharat Biotech International Limited | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-337 | Poliomyelitis vaccines (bivalent live, oral, innactivated, type 1, 3) | BIOPOLIO B1/3 | Liquid: Ready to use | Vial | 10 | Bharat Biotech International Limited | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-453 | Covid-19, protein subunit | BIRMEVAX | Liquid: Ready to use | Vial | 1 | HIPRA HUMAN HEALTH, S.L.U | European Medicines Agency | |
| FVP-P-422 | Poliomyelitis vaccines (bivalent live, oral, innactivated, type 1, 3) | Bivalent OPV Type 1 and 3 Poliomyelitis Vaccine Live (Oral) | Liquid: Ready to use | Vial | 10 | Panacea Biotec Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-335 | Poliomyelitis vaccines (bivalent live, oral, innactivated, type 1, 3) | Bivalent OPV Type 1 and 3 Poliomyelitis Vaccine Live (Oral) | Liquid: Ready to use | Vial | 20 | Panacea Biotec Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-195 | Poliomyelitis vaccines (bivalent live, oral, innactivated, type 1, 3) | Bivalent Oral Poliomyelitis Vaccine Type 1&3 (bOPV 1&3) | Liquid: Ready to use | Vial | 20 | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia (NADFCI) | |
| FVP-P-297 | Poliomyelitis vaccines (bivalent live, oral, innactivated, type 1, 3) | Bivalent Oral Poliomyelitis Vaccine Type 1&3 (bOPV 1&3) | Liquid: Ready to use | Vial | 10 | PT Bio Farma (Persero) | National Agency of Drug and Food Control Indonesia (NADFCI) | |
| FVP-P-200 | Poliomyelitis vaccines (bivalent live, oral, innactivated, type 1, 3) | Bivalent type 1&3 Oral Poliomyelitis vaccine IP (bOPV1&3) | Liquid: Ready to use | Vial | 20 | Haffkine Bio Pharmaceutical Corporation Ltd | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-266 | Diphtheria, tetanus and (acellular) pertussis vaccine (adsorbed) | Boostrix | Liquid: Ready to use | Vial | 1 | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products (FAMPH) | |
| FVP-P-389 | Recombinant human papillomavirus virus-like particle vaccine (types 16,18) | Cecolin® | Liquid: Ready to use | Vial | 1 | Xiamen Innovax Biotech Co. Ltd. | National Medical Products Administration (NMPA) | |
| FVP-P-210 | Human pandemic influenza vaccine | Celtura | Liquid: Ready to use | Vial | 17 | Seqirus GmbH | Paul Ehrlich Institute | |
| FVP-P-179 | Recombinant human papillomavirus virus-like particle vaccine (types 16,18) | Cervarix | Liquid: Ready to use | Vial | 1 | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products (FAMPH) | |
| FVP-P-180 | Recombinant human papillomavirus virus-like particle vaccine (types 16,18) | Cervarix | Liquid: Ready to use | Vial | 2 | GlaxoSmithKline Biologicals SA | Federal Agency for Medicines and Health Products (FAMPH) | |
| FVP-P-447 | Recombinant malaria vaccine | CYVAC | Liquid: Ready to use | Vial | 2 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-446 | Recombinant malaria vaccine | CYVAC | Liquid: Ready to use | Vial | 1 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-329 | Dengue tetravalent vaccine (live, attenuated) | Dengvaxia | Lyophilised active component to be reconstituted with excipient diluent before use | Two vial set (active + excipient) | 5 | Sanofi Pasteur SA | Agence nationale de sécurité du médicament et des produits de santé (ANSM) | |
| FVP-P-77 | Diphtheria and tetanus vaccine (adsorbed) | Diftet | Liquid: Ready to use | Vial | 10 | Bul Bio-National Center of Infectious and Parasitic Diseases Ltd. | Bulgarian Drug Agency (BDA) | |
| FVP-P-78 | Diphtheria and tetanus vaccine (adsorbed) | Diftet | Liquid: Ready to use | Vial | 20 | Bul Bio-National Center of Infectious and Parasitic Diseases Ltd. | Bulgarian Drug Agency (BDA) | |
| FVP-P-118 | Diphtheria and tetanus vaccine (adsorbed) | Diphtheria and Tetanus Vaccine Adsorbed (Paediatric) | Liquid: Ready to use | Ampoule | 1 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-120 | Diphtheria and tetanus vaccine (adsorbed) | Diphtheria and Tetanus Vaccine Adsorbed (Pediatric) | Liquid: Ready to use | Vial | 20 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-119 | Diphtheria and tetanus vaccine (adsorbed) | Diphtheria and Tetanus Vaccine Adsorbed (Pediatric) | Liquid: Ready to use | Vial | 10 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-122 | Diphtheria and tetanus vaccine (adsorbed, reduced diphtheria antigen content) | Diphtheria and Tetanus Vaccine Adsorbed for Adults and Adolescents | Liquid: Ready to use | Vial | 10 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-121 | Diphtheria and tetanus vaccine (adsorbed, reduced diphtheria antigen content) | Diphtheria and Tetanus Vaccine Adsorbed for Adults and Adolescents | Liquid: Ready to use | Ampoule | 1 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-123 | Diphtheria and tetanus vaccine (adsorbed, reduced diphtheria antigen content) | Diphtheria and Tetanus Vaccine Adsorbed for Adults and Adolescents | Liquid: Ready to use | Vial | 20 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-216 | Diphtheria, tetanus, pertussis and (+) Haemophilus influenzae type b conjugate vaccine (adsorbed) | Diphtheria Tetanus Pertussis and Haemophilus influenzae type b Conjugate Vaccine | Lyophilised active component to be reconstituted with liquid active component before use | Vial + Ampoule | 1 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-128 | Diphtheria, tetanus, whole-cell pertussis and recombinant hepatitis B vaccine (adsorbed) | Diphtheria Tetanus Pertussis and Hepatitis B Vaccine Adsorbed | Liquid: Ready to use | Vial | 10 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-127 | Diphtheria, tetanus, whole-cell pertussis and recombinant hepatitis B vaccine (adsorbed) | Diphtheria Tetanus Pertussis and Hepatitis B Vaccine Adsorbed | Liquid: Ready to use | Ampoule | 1 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-129 | Diphtheria, tetanus, whole-cell pertussis and recombinant hepatitis B vaccine (adsorbed) | Diphtheria Tetanus Pertussis and Hepatitis B Vaccine Adsorbed | Liquid: Ready to use | Vial | 20 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-204 | Diphtheria, tetanus, pertussis, hepatitis B and (+) Haemophilus influenzae type b conjugate vaccine (adsorbed) | Diphtheria Tetanus Pertussis Hepatitis B and Haemophilus influenzae type b Conjugate Vaccine | Lyophilised active component to be reconstituted with liquid active component before use | Vial + Ampoule | 10 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-203 | Diphtheria, tetanus, pertussis, hepatitis B and (+) Haemophilus influenzae type b conjugate vaccine (adsorbed) | Diphtheria Tetanus Pertussis Hepatitis B and Haemophilus influenzae type b Conjugate Vaccine | Lyophilised active component to be reconstituted with liquid active component before use | Vial + Ampoule | 2 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-194 | Diphtheria, tetanus, pertussis, hepatitis B and (+) Haemophilus influenzae type b conjugate vaccine (adsorbed) | Diphtheria Tetanus Pertussis Hepatitis B and Haemophilus influenzae type b Conjugate Vaccine | Lyophilised active component to be reconstituted with liquid active component before use | Vial + Ampoule | 1 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-223 | Diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b conjugate vaccine (adsorbed) | Diphtheria Tetanus Pertussis Hepatitis B and Haemophilus influenzae type b Conjugate Vaccine Adsorbed | Liquid: Ready to use | Vial | 1 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-224 | Diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b conjugate vaccine (adsorbed) | Diphtheria Tetanus Pertussis Hepatitis B and Haemophilus influenzae type b Conjugate Vaccine Adsorbed | Liquid: Ready to use | Vial | 2 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) | |
| FVP-P-225 | Diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b conjugate vaccine (adsorbed) | Diphtheria Tetanus Pertussis Hepatitis B and Haemophilus influenzae type b Conjugate Vaccine Adsorbed | Liquid: Ready to use | Vial | 10 | Serum Institute of India Pvt. Ltd. | Central Drugs Standard Control Organization (CDSCO) |
.